
STAAR Surgical Company
STAANASDAQHealthcareMedical - Instruments & Supplies
Previous close
$23.14
+$0.07 · +0.30%
STAA company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
49
Fair Value
Momentum
46
Neutral
Sentiment
68
Bullish
Risk resilience
49
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteSTAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated injector systems, crucial for cataract surgery. The company also sells various injector components and ancillary medical instruments and devices. Its market outreach extends to a diverse array of healthcare providers, such as ophthalmic surgeons, specialized vision and surgical centers, hospitals, governmental healthcare facilities, and distributors. These products are predominantly utilized by ophthalmologists. Sales are conducted directly via its own sales force in key countries like the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. In other significant markets, including China, Korea, India, France, the Benelux region, Italy, and other international territories, the company employs a hybrid sales model, leveraging both its direct representatives and independent distributors. Founded in 1982, STAAR Surgical Company is headquartered in Lake Forest, California.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Warren Foust
- Listed since
- Feb 24, 1992
- Employees
- 921
Market position
Day range
Current $23.14
52-week range
Current $23.14
- Open
- $23.15
- Previous close
- $23.07
- Volume
- 698.5K
- 0.77× average
- Average volume
- 905.67K
- Average daily volume
- Market cap
- 1.15B USD
- Beta
- 1.23
- Market reference 1
- 50-day average
- $26.2818
- -11.95% below average
- 200-day average
- $24.2038
- -4.39% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 1.06B USD
- P/E (TTM)
- 289.25×
- P/B (TTM)
- 3.19×
- P/S (TTM)
- 3.39×
- EV / EBITDA
- -14.35×
- Earnings yield
- -6.88%
- Free cash flow yield
- -3.42%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 76.23%
- Operating margin
- 10.32%
- Net margin
- 1.13%
- Return on equity
- -23.37%
- Return on assets
- -17.43%
- Return on invested capital
- -11.26%
Financial health
- Debt / equity
- 0.1×
- Current ratio
- 4.55×
- Altman Z-score
- 7.45
- Piotroski F-score
- 4 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 239.44M USD | 313.9M USD | 322.42M USD | 284.39M USD | 230.47M USD |
| Cost of goods sold | 57.02M USD | 74.32M USD | 69.76M USD | 61.01M USD | 51.84M USD |
| Gross profit | 182.42M USD | 239.58M USD | 252.65M USD | 223.38M USD | 178.64M USD |
| Research and development | 40.06M USD | 53.97M USD | 44.4M USD | 35.98M USD | 33.86M USD |
| Selling, general, and administrative | 188.31M USD | 198.22M USD | 180.15M USD | 143.6M USD | 111.44M USD |
| Operating expenses | 228.37M USD | 252.19M USD | 224.55M USD | 179.58M USD | 145.3M USD |
| Interest income | 4.59M USD | 5.91M USD | 6.99M USD | 2.45M USD | — |
| Interest expense | — | — | — | — | 38K USD |
| Depreciation and amortization | 8.73M USD | 6.89M USD | 5.12M USD | 4.51M USD | 3.64M USD |
| Operating income | −45.95M USD | −12.61M USD | 28.1M USD | 43.8M USD | 33.34M USD |
| Net income | −80.45M USD | −20.21M USD | 21.35M USD | 39.67M USD | 27.51M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 64%
- 7 beats, 4 misses, 0 met estimates
- Average EPS surprise
- -172.75%
- 11 comparable reports
- Latest EPS result
- 0.16
- Estimate 0.22 · Miss by 27.73%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$31.50
36.13% upsideRating distribution
16 ratingsRecent analyst actions
STAA news
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | May 18, 1992 | 1:2 | — | — |
Stock split | Nov 1, 1990 | 1:2 | — | — |
Stock split | Nov 9, 1984 | 2:1 | — | — |
Stock split | Jul 3, 1984 | 2:1 | — | — |
Effective May 18, 1992
1:2
Effective Nov 1, 1990
1:2
Effective Nov 9, 1984
2:1
Effective Jul 3, 1984
2:1
STAA peers
ETFs holding STAA
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR73.02M0.06%111.19B USD0.06%$147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI23.13M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM20.07M0.02%81.62B USD0.19%$299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB16.72M0.01%183.4B USD0.03%$304.76+0.64%
Vanguard Extended Market ETFVXF14.02M0.01%93.7B USD0.05%$245.53+0.82%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM10.76M0.06%17.03B USD0.03%$57.28+0.61%
Vanguard Morningstar Small-Cap Growth ETFVBK9.6M0.02%43.8B USD0.05%$358.65+0.70%
iShares Russell 2000 Growth ETFIWO6.57M0.04%15.16B USD0.24%$387.37+1.24%
iShares Core S&P Small-Cap ETFIJR- Market value
- 73.02M
- Weight
- 0.06%
- AUM
- 111.19B USD
- Expense ratio
- 0.06%
- Price / 1D
- $147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 23.13M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 20.07M
- Weight
- 0.02%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 16.72M
- Weight
- 0.01%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Extended Market ETFVXF- Market value
- 14.02M
- Weight
- 0.01%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM- Market value
- 10.76M
- Weight
- 0.06%
- AUM
- 17.03B USD
- Expense ratio
- 0.03%
- Price / 1D
- $57.28+0.61%
Vanguard Morningstar Small-Cap Growth ETFVBK- Market value
- 9.6M
- Weight
- 0.02%
- AUM
- 43.8B USD
- Expense ratio
- 0.05%
- Price / 1D
- $358.65+0.70%
iShares Russell 2000 Growth ETFIWO- Market value
- 6.57M
- Weight
- 0.04%
- AUM
- 15.16B USD
- Expense ratio
- 0.24%
- Price / 1D
- $387.37+1.24%
Continue in GoAI
Research STAAresearch.disclaimer











